This page offers an easy way for policymakers to access health research and analysis that is relevant to current Congressional agendas. For additional information, to request documents, or to arrange a briefing, contact the RAND Office of Congressional Relations at ocr@rand.org or (703) 413-1100, ext. 5643.
RAND periodically sends alerts and newsletters to update Congress on highlights of recent work about health and health care.
Testimony presented before the Senate Committee on Homeland Security and Governmental Affairs on June 24, 2020.
Document submitted on June 23, 2020, as an addendum to testimony before the U.S.-China Economic and Security Review Commission on May 7, 2020.
Testimony presented before the U.S.-China Economic and Security Review Commission on May 7, 2020.
Remarks presented to the House Science, Space, and Technology Committee at a virtual roundtable on May 5, 2020.
Document submitted March 5, 2020, as an addendum to testimony before the House Foreign Affairs Subcommittee on Asia, the Pacific, and Nonproliferation on February 5, 2020.
Testimony presented before the House Small Business Committee on March 10, 2020.
Testimony presented before the House Foreign Affairs Subcommittee on Asia, the Pacific, and Nonproliferation on February 5, 2020.
Testimony presented before the California State Assembly and Senate Committees on Health on January 28, 2020.
Document submitted January 21, 2020, as an addendum to testimony before the Senate Judiciary Committee Hearing on Opioids on December 17, 2019.
Testimony presented before the Senate Judiciary Committee on December 17, 2019.
Testimony presented before an informational hearing of the California State Assembly Committee on Budget on December 9, 2019.
Testimony presented before the Pennsylvania State Senate Judiciary Committee on September 25, 2019.
Document submitted on August 19, 2019, as an addendum to testimony before the U.S.-China Economic and Security Review Commission on July 31, 2019.
Document submitted on August 19, 2019, as an addendum to testimony before the House Committee on Homeland Security, Subcommittee on Intelligence and Counterterrorism and Subcommittee on Border Security, Facilitation, and Operations on July 25, 2019.
Testimony presented before the U.S.-China Economic and Security Review Commission on July 31, 2019.
Testimony presented before the House Committee on Homeland Security, Subcommittee on Intelligence and Counterterrorism and Subcommittee on Border Security, Facilitation, and Operations, on July 25, 2019.
Testimony presented before the House Oversight and Reform Subcommittee on National Security on May 8, 2019.
Testimony presented before the House Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on March 7, 2019.
Testimony presented before the House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations on September 6, 2018.
Testimony presented before the California Mental Health Services Oversight and Accountability Commission on May 24, 2018.
Testimony presented before the Standing Committee on Social Affairs, Science, and Technology Senate of Canada on May 7, 2018.
Testimony presented before the House of Commons of Canada Standing Committee on Health on September 14, 2017.
Testimony presented before the Senate Special Committee on Aging on June 14, 2017.
Testimony presented before the House Appropriations Committee, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on April 5, 2017.
Testimony presented before the Florida House of Representatives Health & Human Services Committee, Subcommittee on Health Quality on January 25, 2017.
Testimony submitted to the Senate Finance Committee, Subcommittee on Health Care on July 13, 2016.
Document submitted on June 5, 2014 as an addendum to testimony presented before the House Energy and Commerce Committee, Subcommittee on Health on May 1, 2014.
Testimony presented before the House Energy and Commerce Committee, Subcommittee on Health on May 1, 2014.
Document submitted on April 16, 2014 as an addendum to testimony presented before the House Ways and Means Committee, Subcommittee on Human Resources on April 2, 2014.
Testimony presented before the House Ways and Means Committee, Subcommittee on Human Resources on April 2, 2014.
Testimony presented before the Senate Appropriations Committee, Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on February 26, 2014.
Testimony presented before the California State Senate Select Committee on Mental Health on September 24, 2013.
Document submitted on July 12, 2013 as an addendum to testimony presented before the Senate Special Committee on Aging on April 24, 2013.
Document submitted on July 12, 2013 as an addendum to testimony presented before the House Energy and Commerce Committee, Subcommittee on Health on June 5, 2013.
Testimony presented before the Senate Homeland Security and Governmental Affairs Committee on July 10, 2013.
Testimony presented before the House Energy and Commerce Committee, Subcommittee on Health June 12, 2013.
Testimony presented before the House Energy and Commerce Committee, Subcommittee on Health on June 5, 2013.
Testimony presented before the Senate Special Committee on Aging on April 24, 2013.
Testimony presented before the House Energy and Commerce Committee, Subcommittee on Health on February 14, 2013.
Testimony presented before the California State Senate Labor and Industrial Relations Committee on May 9, 2012.
Testimony presented before the House Committee on Ways and Means, Subcommittee on Social Security on March 20, 2012.
Testimony presented before the House Veterans' Affairs Committee, Subcommittee on Health on December 2, 2011.
Testimony presented before the Senate Veterans' Affairs Committee on July 27, 2011.
Testimony presented before the California State Assembly Subcommittee on Education on April 2, 2008.
Testimony presented to Public Meeting on Research Needs Related to the Environmental, Health, and Safety Aspects of Engineered Nanoscale Materials on January 4, 2007.
Testimony presented to the California Little Hoover Commission on June 23, 2005.
Testimony presented to the Oregon State Senate and House Judiciary Committees on March 17, 2005.
Testimony submitted to the United States Senate Committee on Health, Education, Labor and Pensions field hearing on "9/11 and NYC Children" June 10, 2002.
Testimony presented at a hearing of the California State Assembly Budget Subcommittee No. 1 on Health and Human Services (Assembly member Gilbert Cedillo, Chair) meeting in Sacramento, California, on February 15, 2000.
Testimony presented at a hearing of the California State Senate Committee on Health and Human Services meeting in Montebello, California, on December 8, 1999.
In this brief, the authors present methods for creating critical care surge capacity in hospitals in response to the COVID-19 pandemic and estimate patient capacity, given the number of doctors, nurses, respiratory therapists, ventilators, and beds.
This brief describes how a public option for health care—that is, a government-sponsored health insurance plan with publicly determined provider payment rates—would affect insurance costs and coverage.
This brief describes the results of an interim evaluation that examined the scope, content, and dissemination of mental health public awareness campaigns. RAND researchers conducted a comprehensive evaluation of four such efforts.
In light of the challenges facing the NHS, RAND Europe and the University of Manchester were asked to conduct a study on the potential of innovation to help deliver an efficient and effective healthcare service.
In this brief, RAND researchers, in support of Army efforts to provide the highest-quality behavioral health care possible, identify factors associated with changes in outcomes for soldiers who receive Army behavioral health specialty care.
